113 results
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
2 May 24
Agios Reports Business Highlights and First Quarter 2024 Financial Results
7:01am
of its drug development, including PYRUKYND®, AG-946 and AG-181, its PAH stabilizer; Agios’ strategic vision and goals, including its key milestones … of pandemics or other public health emergencies to Agios’ business, operations, strategy, goals and anticipated milestones, including its ongoing
8-K
EX-99.1
AGIO
Agios Pharmaceuticals Inc
15 Feb 24
Agios Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights
7:03am
; Agios’ strategic vision and goals, including its key milestones for 2024; and the potential benefits of Agios’ strategic plans and focus. The words … , goals and anticipated milestones, including its ongoing and planned research activities, ability to conduct ongoing and planned clinical trials
8-K
EX-99.1
fo69thq
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.2
v5q5z7 l21lc83k
8 Jan 24
Agios Announces Key Anticipated 2024 Milestones Across Rare Disease Portfolio
7:58am
8-K
EX-99.1
lkspdh
2 Nov 23
Agios Reports Business Highlights and Third Quarter 2023 Financial Results
7:02am
8-K
EX-99.1
jxso9h4otms9cl1n
3 Aug 23
Agios Reports Business Highlights and Second Quarter 2023 Financial Results
6:38am
S-8
EX-99.1
owd7kayzqexvmv45x
13 Jun 23
Registration of securities for employees
4:13pm
8-K
EX-99.1
1bgsl 6tcudjjilr32wa
4 May 23
Agios Reports Business Highlights and First Quarter 2023 Financial Results
7:03am
8-K
2t1hr 069r
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
8io72lnb7ypjlt
6 Dec 22
Agios Appoints Tsveta Milanova as Chief Commercial Officer
7:37am
8-K
EX-99.1
szz9j9 z0vs3zne6i
3 Nov 22
Agios Reports Business Highlights and Third Quarter 2022 Financial Results
7:02am